HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

David F Bishop Selected Research

X-linked sideroblastic anemia

1/2019Molecular expression, characterization and mechanism of ALAS2 gain-of-function mutants.
8/2012X-linked sideroblastic anemia due to carboxyl-terminal ALAS2 mutations that cause loss of binding to the β-subunit of succinyl-CoA synthetase (SUCLA2).
7/2003A promoter mutation in the erythroid-specific 5-aminolevulinate synthase (ALAS2) gene causes X-linked sideroblastic anemia.
12/2002Absent phenotypic expression of X-linked sideroblastic anemia in one of 2 brothers with a novel ALAS2 mutation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


David F Bishop Research Topics

Disease

6Erythropoietic Porphyria (Congenital Erythropoietic Porphyria)
01/2011 - 06/2002
4X-linked sideroblastic anemia
01/2019 - 12/2002
4Acute Intermittent Porphyria (Porphyria, Acute)
02/2010 - 11/2004
3Porphyrias (Porphyria)
01/2020 - 11/2004
2Liver Diseases (Liver Disease)
04/2013 - 03/2013
2Anemia
01/2009 - 04/2006
1Photosensitivity Disorders (Photodermatitis)
01/2018
1Erythropoietic Protoporphyria
04/2013
1Hereditary Coproporphyria (Coproporphyrinogen Oxidase Deficiency)
02/2011
1Harderoporphyria
02/2011
1Hypochromic Anemia (Chlorosis)
01/2011
1Hepatic Porphyrias (Hepatic Porphyria)
01/2010
1Polycythemia (Erythrocytosis)
01/2009
1Reticulocytosis
04/2006
1Hemolytic Anemia
04/2006
1Neurologic Manifestations (Neurological Manifestations)
11/2004

Drug/Important Bio-Agent (IBA)

8Heme (Haem)IBA
01/2020 - 06/2002
5Uroporphyrinogen III Synthetase (Uroporphyrinogen-III Synthase)IBA
01/2011 - 06/2002
4EnzymesIBA
01/2019 - 04/2006
4PorphyrinsIBA
01/2011 - 11/2004
4Hydroxymethylbilane Synthase (Porphobilinogen Deaminase)IBA
02/2010 - 11/2004
2AcidsIBA
01/2018 - 12/2002
2protoporphyrin IXIBA
01/2018 - 04/2013
25-Aminolevulinate SynthetaseIBA
04/2013 - 07/2003
2Acute Hepatic PorphyriaIBA
02/2011 - 02/2010
1NucleotidesIBA
01/2019
1succinyl-coenzyme A (succinyl-CoA)IBA
01/2019
11-phenyl-3,3-dimethyltriazene (PDT)IBA
01/2018
1Ferrochelatase (Heme Synthetase)IBA
04/2013
1ProtoporphyrinsIBA
03/2013
1Peptides (Polypeptides)IBA
03/2013
1Succinate-CoA Ligases (Succinyl Coenzyme A Synthetases)IBA
08/2012
1Aminolevulinic Acid (Levulan)FDA Link
08/2012
1Coproporphyrinogen Oxidase (Coproporphyrinogen III Oxidases)IBA
02/2011
1coproporphyrin IIIIBA
02/2011
1Hemoglobins (Hemoglobin)IBA
01/2011
1ErythropoietinFDA Link
01/2009
1Dimethyl Sulfoxide (DMSO)FDA LinkGeneric
01/2009

Therapy/Procedure

1Therapeutics
01/2020
1Photochemotherapy (Photodynamic Therapy)
01/2018